BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 29
• 30
• 31

• Pharm Country

  The Medicines Company to Participate in the Jefferies and Co. 2012 Global Healthcare Conference

  May 30, 2012

   · 

  1 min read
• Business

  MorphoSys AG Announces New Management Appointments

  May 30, 2012

   · 

  3 min read
• MorphoSys AG to Present at Jefferies and Co. 2012 Global Healthcare Conference in June

  May 30, 2012

   · 

  2 min read
• Ablynx Announces Webcast of Its Presentation at the Annual Jefferies and Co. 2012 Global Healthcare Conference

  May 30, 2012

   · 

  1 min read
• Biotech Bay

  Threshold Pharmaceuticals, Inc. Announces Presentation and Webcast at Jefferies and Co. Global Healthcare Conference

  May 30, 2012

   · 

  1 min read
• BioCapital

  Seegene, Inc. Develops Industry’s First Real-Time “Multiplex Quantification” Molecular Diagnostic Testing Technology

  May 30, 2012

   · 

  2 min read
• Pharm Country

  Kadmon to Present at the Jefferies and Co. 2012 Global Healthcare Conference

  May 30, 2012

   · 

  1 min read
• Policy

  Medivation, Inc. and Astellas Pharma Inc. Announce Initiation of Expanded Access Program for Enzalutamide (formerly MDV3100) in the United States

  May 30, 2012

   · 

  5 min read
• Genetown

  Cellceutix Adds Brain Cancer to Growing List of Indications for Its Novel Cancer Drug

  May 30, 2012

   · 

  4 min read
• Drug Development

  Celsion Corporation Announces Completion of Enrollment in Its Pivotal Phase III HEAT Study of ThermoDox(R) in Primary Liver Cancer

  May 30, 2012

   · 

  5 min read